Versigent (NYSE:VGNT) Raised to Strong-Buy at The Goldman Sachs Group

Versigent (NYSE:VGNT) was upgraded by The Goldman Sachs Group to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

Other analysts have also recently issued research reports about the stock. Royal Bank Of Canada upped their price objective on shares of Versigent from $34.00 to $41.00 and gave the company a “sector perform” rating in a research report on Monday, July 13th. Zacks Research upgraded Versigent from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft raised Versigent from a “hold” rating to a “buy” rating and set a $50.00 target price for the company in a research note on Tuesday, July 7th. BNP Paribas Exane began coverage on Versigent in a report on Tuesday, April 28th. They issued an “outperform” rating and a $41.00 price target for the company. Finally, Evercore reaffirmed an “outperform” rating and set a $60.00 price target on shares of Versigent in a research report on Monday, May 18th. Three equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Versigent presently has a consensus rating of “Buy” and a consensus price target of $49.67.

Versigent Trading Up 2.8%

VGNT opened at $41.15 on Monday. The stock has a fifty day moving average price of $43.42. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88.